LATEST HEALTH NEWS
Hyderabad-based vaccine and pharmaceutical company Biological E. Limited (BE) announced on Saturday that its COVID-19 subunit vaccine candidate has received approval to begin Phase III trials in India.
from Medindia Health News https://ift.tt/32OyZ9E
No comments
Thanks for comment via will connect you within 24 hours.